Search Results - "Bodar, Yves J.L."

Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer by Jansen, Bernard HE, Cysouw, Matthijs CF, Vis, André N, van Moorselaar, Reindert JA, Voortman, Jens, Bodar, Yves JL, Schober, Patrick R, Hendrikse, N Harry, Hoekstra, Otto S, Boellaard, Ronald, Oprea-Lager, DE

“…Quantitative evaluation of radiolabeled prostate-specific membrane antigen (PSMA) PET scans may be used to monitor treatment response in patients with prostate…”
Get full text

Exophthalmos as the initial presentation of metastatic prostate cancer by Duijn, Matthijs, Hovius, Marina C., Seedo, Gyorgio J., Baars, Philippe C., Bodar, Yves J.L.

“…Primary metastatic prostate cancer to the orbit is exceedingly rare. Benign lesions, including meningioma, have demonstrated PSMA expression and can be…”
Get full text

MP62-16 A PROSPECTIVE EVALUATION OF PELVIC LYMPH NODE STAGING WITH 18 FLUORINE PROSTATE-SPECIFIC MEMBRANE ANTIGEN PET/CT PRIOR TO EXTENDED LYMPH NODE DISSECTION IN PRIMARY PROSTATE CANCER. THE SALT STUDY by Bodar, Yves J.L., Jansen, B.H.E., Zwezerijnen, G.J.C., Nieuwenhuijzen, J.A., Wondergem, M., Roeleveld, T.A., Hoekstra, O.S., van Moorselaar, R.J.A., Oprea-Lager, D.E., Vis, A.N.

Get full text

Standardised uptake values as determined on prostate‐specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer by Bodar, Yves J.L., Veerman, Hans, Meijer, Dennie, de Bie, Katelijne, van Leeuwen, Pim J., Donswijk, Maarten L., van Moorselaar, R. Jeroen A., Hendrikse, N. Harry, Boellaard, Ronald, Oprea‐Lager, Daniela E., Vis, André N.

“…Objectives To investigate the association between intraprostatic, intratumoral maximum standardised uptake values (SUVmax) on prostate‐specific membrane…”
Get full text

Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study by Bodar, Yves J. L., Zwezerijnen, Ben G. J. C., van der Voorn, Patrick J., Jansen, Bernard H. E., Smit, Ruth S., Kol, Sabrine Q., Meijer, Dennie, de Bie, Katelijne, Yaqub, Maqsood, Windhorst, Bert A. D., Hendrikse, Harry N. H., Vis, André N., Oprea-Lager, Daniela E.

“…Purpose Multiparametric magnetic resonance imaging (mpMRI) is a well-established imaging method for localizing primary prostate cancer (PCa) and for guiding…”
Get full text

The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer by Meijer, Dennie, de Barros, Hilda A, van Leeuwen, Pim J, Bodar, Yves J L, van der Poel, Henk G, Donswijk, Maarten L, Hendrikse, N Harry, van Moorselaar, R Jeroen A, Nieuwenhuijzen, Jakko A, Oprea-Lager, Daniela E, Vis, André N

“…We sought to identify a subset of patients in whom an extended pelvic lymph node dissection during robot-assisted laparoscopic radical prostatectomy for…”
Get full text

Using prostate‐specific membrane antigen positron‐emission tomography to guide prostate biopsies and stage men at high‐risk of prostate cancer by Bodar, Yves J.L., Boevé, Liselotte M.S., Leeuwen, Pim J., Baars, Phillippe C., Nieuwenhuijzen, Jakko A., Haarst, Ernst P., Oddens, Jorg R., Donswijk, Maarten L., Riel, Luigi A. M. J. G., Scheltema, Matthijs J., Meijer, Dennie, Hendrikse, N. Harry, Oprea‐Lager, Daniela E., Vis, André N.

“…Objective To assess whether a diagnostic pathway in which prostate‐specific membrane antigen (PSMA) positron‐emission tomography (PET)/computed tomography (CT)…”
Get full text

SUVs Are Adequate Measures of Lesional 18 F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden by Bodar, Yves J L, Koene, Berend P F, Jansen, Bernard H E, Cysouw, Matthijs C F, Meijer, Dennie, Hendrikse, N Harry, Vis, André N, Boellaard, Ronald, Oprea-Lager, Daniela E

“…In prostate cancer (PCa) patients, the tumor-to-blood ratio (TBR) has been validated as the preferred simplified method for lesional F-DCFPyL (a radiolabeled…”
Get full text

The oncological characteristics of non‐prostate‐specific membrane antigen (PSMA)‐expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography by Veerman, Hans, Donswijk, Maarten, Bekers, Elise, Bodar, Yves J.L., Meijer, Dennie, Moorselaar, R. Jeroen A., Oprea‐Lager, Daniela E., Noort, Vincent, Leeuwen, Pim J., Vis, André N., Poel, Henk G.

Get full text

Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging by Meijer, Dennie, Donswijk, Maarten L, Bodar, Yves J L, van Leeuwen, Pim J, Poel, Henk G van der, Vogel, Wouter V, Nieuwenhuijzen, Jakko A, Hendrikse, N Harry, Oprea-Lager, Daniela E, Vis, André N

“…Since the introduction of radiolabeled prostate-specific membrane antigen (PSMA) PET/CT, the ability to visualize recurrent prostate cancer has improved…”
Get full text

The clinical characteristics of patients with primary non‐prostate‐specific membrane antigen‐expressing prostate cancer on preoperative positron emission tomography/computed tomography by Veerman, Hans, Donswijk, Maarten, Bekers, Elise, olde Heuvel, Judith, Bodar, Yves J.L., Boellaard, Thierry N., Montfoort, Maurits L., Moorselaar, R. Jeroen A., Oprea‐Lager, Daniela E., Leeuwen, Pim J., Vis, André N., Poel, Henk G.

Get full text

Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer by Meijer, Dennie, Luiting, Henk B, van Leeuwen, Pim J, Remmers, Sebastiaan, Jansen, Bernard H E, Bodar, Yves J L, Witteveen, Thelma, Schaake, Eva E, van der Poel, Henk G, Wondergem, Maurits, Busstra, Martijn B, Nieuwenhuijzen, Jakko A, Meijnen, Philip, Brabander, Tessa, van Moorselaar, R Jeroen A, Hendrikse, N Harry, Oprea-Lager, Daniela E, Roobol, Monique J, Vis, André N

“…We assessed predictors of short-term oncologic outcomes of patients who underwent salvage radiation therapy for biochemical recurrence after robot-assisted…”
Get full text

Repeatability of Quantitative 18 F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer by Jansen, Bernard H E, Cysouw, Matthijs C F, Vis, André N, van Moorselaar, Reindert J A, Voortman, Jens, Bodar, Yves J L, Schober, Patrick R, Hendrikse, N Harry, Hoekstra, Otto S, Boellaard, Ronald, Oprea-Lager, D E

“…Quantitative evaluation of radiolabeled prostate-specific membrane antigen (PSMA) PET scans may be used to monitor treatment response in patients with prostate…”
Get full text

Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer by Meijer, Dennie, Jansen, Bernard H. E., Wondergem, Maurits, Bodar, Yves J. L., Srbljin, Sandra, Vellekoop, Annelies E., Keizer, Bram, van der Zant, Friso M., Hoekstra, Otto S., Nieuwenhuijzen, Jakko A., Dahele, Max, Vis, André N., Oprea-Lager, Daniela E.

“…Purpose Radiolabeled Prostate-Specific Membrane Antigen (PSMA) PET/CT is the current standard-of-care for lesion detection in patients with biochemically…”
Get full text

Slow induction of brain death leads to decreased renal function and increased hepatic apoptosis in rats by Rebolledo, Rolando A, Hoeksma, Dane, Hottenrott, Christina M V, Bodar, Yves J L, Ottens, Petra J, Wiersema-Buist, Janneka, Leuvenink, Henri G D

“…Donor brain death (BD) is an independent risk factor for graft survival in recipients. While in some patients BD results from a fast increase in intracranial…”
Get full text

Higher Preoperative Maximum Standardised Uptake Values (SUV max ) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [ 68 Ga]Ga-PSMA-11 and [ 18 F]DCFPyL Positron Emission Tomography/Computed Tomography by de Bie, Katelijne C C, Veerman, Hans, Bodar, Yves J L, Meijer, Dennie, van Leeuwen, Pim J, van der Poel, Henk G, Donswijk, Maarten L, Vis, André N, Oprea-Lager, Daniela E

“…This study aimed to investigate the association between the Ga- or F-radiolabeled prostate-specific membrane antigen (PSMA) tracer expression, represented by…”
Get full text

Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography by Meijer, Dennie, van Leeuwen, Pim J., Eppinga, Wietse S.C., Vanneste, Ben G.L., Meijnen, Philip, Daniels, Laurien A., van den Bergh, Roderick C.N., Lont, Anne P., Bodar, Yves J.L., Ettema, Rosemarijn H., de Bie, Katelijne C.C., Oudshoorn, Frederik H.K., Nieuwenhuijzen, Jakko A., van der Poel, Henk G., Donswijk, Maarten L., Heymans, Martijn W., Oprea-Lager, Daniela E., Schaake, Eva E., Vis, André N.

“…We developed a novel nomogram for predicting outcomes of salvage radiation therapy (sRT) after prostate-specific membrane antigen positron emission…”
Get full text

Tumorlokalisaties op PSMA-PET/CT bij patiënten met een persisterend meetbaar PSA na een radicale prostatectomie by Ettema, Rosemarijn H., Meijer, Dennie, Donswijk, Maarten L., Bodar, Yves J. L., van Leeuwen, Pim J., van der Poel, Henk G., Vogel, Wouter V., Nieuwenhuijzen, Jakko A., Hendrikse, N. Harry, Oprea-Lager, Daniela E., Vis, André N.

“…Samenvatting Het doel van deze studie was om de rol van PSMA-PET/CT vast te stellen bij patiënten met biochemische persistentie (BCP) van prostaatkanker na…”
Get full text